English, , 58kb
Guernsey and Germany have today signed a bilateral agreement for exchange of information for tax purposes bringing to 12 the number of such agreements entered into by Guernsey.
English, , 124kb
This note, taken from Chapter 3 of Economic Policy Reforms: Going for Growth 2009, contains information about the progress in implementing reforms in line with the 2008 priorities for Germany.
The Isle of Man and Germany announced that they have signed a bilateral agreement for the exchange of information for tax purposes, bringing to 13 the number of such agreements entered into by the Isle of Man.
Der Bericht „Stärkung von Unternehmertum und wirtschaftlicher Entwicklung in Ostdeutschland: Lernen von lokaler Praxis“ fasst die Ergebnisse eines 2-jährigen Studien- und Aktionsprogrammes zu den Herausforderungen und Möglichkeiten in der Förderung von Unternehmertum in Ostdeutschland zusammen
The report "Strengthening entrepreneurship and economic development in East Germany: Lessons from local approaches" is the result of a two-year work programme on the challenges and opportunities for entrepreneurship development in East Germany.
Given the crisis, the global governance architecture is moving faster than anticipated and the need for International Organisations to work together has increased. How can we help the international organisations become stronger, more inclusive and agile?
Joint press release by Chancellor Angela Merkel, OECD, WTO, ILO, IMF and World Bank on the occasion of their meeting on 5 February 2009 in Berlin.
The EU Better Regulation project is a partnership between the OECD and the European Commission. It draws on the initiatives for Better Regulation promoted by both organisations over the last few years.
The City of Berlin participates in the Reviews of Higher Education Institutions (HEIs) in Regional Development 2008-10. This site informs about Berlin, its higher education institutions, and the role Berlin HEIs play in city development.
English, , 771kb
This paper (Health Working Paper No. 39) describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals.